
TSE:NTR
This summary was created by AI, based on 23 opinions in the last 12 months.
Nutrien Ltd. (NTR-T) is seen as a promising investment opportunity by various experts despite recent market fluctuations and geopolitical tensions, particularly related to the Iran war impacting fertilizer components. Many reviews suggest the stock has shown signs of recovering from past downtrends, indicating a potential turnaround. Several experts highlight the importance of its stable dividend and robust retail operations, which provide a cushion against market volatility. While concerns surrounding fluctuating fertilizer prices remain prevalent, there is an overall sentiment that Nutrien is well-positioned for long-term growth, particularly as farmer balance sheets begin to improve and global agricultural demands rise. The consensus leans towards the stock being a solid buy for patient investors looking for long-term gains in the agriculture sector.
(A Top Pick Nov 30/17, Up 12%) There are $500 million of synergies up for grabs after the big merger, which could even be higher. They are ahead of plan in synergizing. Also are selling $5 billion of non-core assets. This week in Chile, they just sold a lithium mine, generating $4 billion in cash that'll go to share buybacks and dividends. There are big gains still to come.
Likes it. It's the biggest crop nutriens player in the world, specifically potash and nitrogens, segments which are improving rapidly, and phosphates less so. As a condition of their merger, $5 billion assets were sold and those may be re-deployed into retail network expansion in South America like Brazil, a huge market. There's also $500 million in synergies to be captured which they are doing ahead of schedule. Expect dividend growth, acquisitions and share buybacks.
They're ahead of their cost synergies target after the potash merger. They have sold off some assets totalling $5 billion. They project $6-8 billion in free cash flow to grow their retail network to buyback 5% of the stocks and raise the dividend. They are seeing an uptick in the Nutrient business. They have signed contracts with China and India where pricing should improve next year and beyond. They will benefit from increased demand. (2.9% dividend, Analysts' price target: $81.90)
This is the merger of Potash and Agrium. He wants to own commodity stocks only when the commodities are going up. Both of their main products, nitrogen and potash, have good outlooks. There is an upcoming shortage of nitrogen. They also have an agricultural retail business that stabilizes the company. Yield 2.8%. (Analysts’ price target is $81.58)
Potash is less of a commodity than in the past. The world needs this commodity around the world. The previous supply situation globally is abating as marginal mines are not being built. This is a good name to own. He prefers to hold base metals instead, where there is even greater growth potential. Yield 2.7%.
(A Top Pick Jan 09/18, Up 4%) They merged with Potash a year ago. Well positioned as crop prices have held. The largest potash producer and there is increasing demand for it. Their retail side is around 35% of their operations. Attractive yield of 3.5% and they are doing some share buy backs. Attractive entry point.